Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Thomas Jefferson University
Thomas Jefferson University
M.D. Anderson Cancer Center
Massachusetts General Hospital